DefEYE: Funding, Investors & Team (Sep 2026)
DefEYE is an eye care startup that is expanding quickly with the goal of changing and customizing therapeutic procedures.
DefEYE has raised $12.0M across 1 funding round on record, the most recent a Seed of $12.0M announced in Oct 2025.
That round is above the $6.5M median round size for Healthcare companies tracked on FundedIQ over the last two years.
DefEYE Company Profile and Key Stats
Latest funding round on record: Oct 2025.
DefEYE Funding Rounds
DefEYE Founders and Leadership Team
Contact details for the DefEYE team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →DefEYE Funding Compared to Other Healthcare Startups
DefEYE's latest round of $12.0M is above the median round in Healthcare. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DefEYE in Healthcare and Sarasota
Companies Similar to DefEYE
Cordance Medical develops radical therapy for a variety of CNS pathology.
Kihealth is launching the world's first blood test capable of identifying diabetes risk before symptoms…
Bioactivx is a healthcare firm that accelerates wound recovery, deliver better outcomes for conditions like…
Pluro's goal is to create a single national platform for IVF and fertility treatment.
Ascilion provides painless extraction and analysis of interstitial fluid with hollow microneedles.
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the…
A multi-format private capital intelligence platform.
TRAXyL invented a new way to install broadband communications by essentially "painting" optical fiber…
Electric Pickle features pickleball courts, outdoor entertainment, and a restaurant with globally inspired…
Atorie is an online platform connecting luxury factories with customers that handles everything from…
Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.
NantOptiFab builds advanced photonic chips and wafers for telecom, AI, defense, and quantum applications.
DefEYE Funding FAQs
What does DefEYE do?
DefEYE is an eye care startup that is expanding quickly with the goal of changing and customizing therapeutic procedures.
How much funding has DefEYE raised?
DefEYE has raised $12.0M across 1 round on record. The most recent is a Seed of $12.0M announced in Oct 2025.
When did DefEYE last raise funding?
DefEYE's most recent funding round on record is a Seed of $12.0M, announced in Oct 2025.
Who is the CEO of DefEYE?
Rob Sambursky, MD is listed as CEO at DefEYE.
Where is DefEYE headquartered?
DefEYE is based in Sarasota, United States.
How many employees does DefEYE have?
DefEYE is in the 11-50 employee band.
How does DefEYE's funding compare to other Healthcare startups?
DefEYE's latest round of $12.0M is above the $6.5M median round size for Healthcare companies on FundedIQ across 9 tracked companies over the last two years.
About FundedIQ's DefEYE Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DefEYE is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.